1. Home
  2. LEGN vs MTG Comparison

LEGN vs MTG Comparison

Compare LEGN & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • MTG
  • Stock Information
  • Founded
  • LEGN 2014
  • MTG 1957
  • Country
  • LEGN United States
  • MTG United States
  • Employees
  • LEGN N/A
  • MTG N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • MTG Property-Casualty Insurers
  • Sector
  • LEGN Health Care
  • MTG Finance
  • Exchange
  • LEGN Nasdaq
  • MTG Nasdaq
  • Market Cap
  • LEGN 7.0B
  • MTG 5.8B
  • IPO Year
  • LEGN 2020
  • MTG 1991
  • Fundamental
  • Price
  • LEGN $31.78
  • MTG $26.18
  • Analyst Decision
  • LEGN Strong Buy
  • MTG Hold
  • Analyst Count
  • LEGN 13
  • MTG 8
  • Target Price
  • LEGN $79.42
  • MTG $26.50
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • MTG 1.8M
  • Earning Date
  • LEGN 05-13-2025
  • MTG 04-30-2025
  • Dividend Yield
  • LEGN N/A
  • MTG 1.99%
  • EPS Growth
  • LEGN N/A
  • MTG 15.33
  • EPS
  • LEGN N/A
  • MTG 3.00
  • Revenue
  • LEGN $627,241,000.00
  • MTG $1,219,604,000.00
  • Revenue This Year
  • LEGN $65.96
  • MTG $3.09
  • Revenue Next Year
  • LEGN $52.55
  • MTG $2.89
  • P/E Ratio
  • LEGN N/A
  • MTG $8.72
  • Revenue Growth
  • LEGN 119.97
  • MTG 4.64
  • 52 Week Low
  • LEGN $29.27
  • MTG $20.11
  • 52 Week High
  • LEGN $60.87
  • MTG $26.56
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.49
  • MTG 64.76
  • Support Level
  • LEGN $30.25
  • MTG $25.84
  • Resistance Level
  • LEGN $35.81
  • MTG $26.59
  • Average True Range (ATR)
  • LEGN 1.45
  • MTG 0.56
  • MACD
  • LEGN -0.18
  • MTG 0.18
  • Stochastic Oscillator
  • LEGN 27.58
  • MTG 86.17

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.

Share on Social Networks: